Qiagen this week announced the release of the Allstars Hs Cell Death Control siRNA, which targets ubiquitous human cell survival genes.
“Transfection of this siRNA blend results in a high degree of cell death which is visible by light microscopy,” the company said. The siRNA can be ordered in tubes in 1-nmol, 5-nmol, or 20-nmol amounts, or in 96-well plates in 1-nmol, 0.25-nmol, or 0.1-nmol amounts.